Drugs / mitolactol
mitolactol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00002620 | Nov 1994 → Jun 2000 | brain cancer | European Organisation for Research and Treatment of Cancer - EORTC | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mitolactol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002620 ↗ |
| Known as | DBD | “with Mitolactol, DBD, NSC-104800; followed by DBD;” NCT00002620 ↗ |
| Known as | Dibromdulcit | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104612 ↗ |
| Known as | Elobromol | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104612 ↗ |
| Known as | NCI-C04795 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104612 ↗ |
| Known as | NSC-104800 | “with Mitolactol, DBD, NSC-104800; followed by DBD;” NCT00002620 ↗ |
| Modality | Small molecule | — CHEMBL2104612 ↗ |